This market is going bananas over tariffs, but there's one area of the market that can still protect your investments. The ...

Q1 stock picks updated with new commentary and ratings. See why Apple’s being dropped and 38 new stocks are covered for the ...

Q4 2024 Earnings Call Transcript March 27, 2025 Plus Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.67 EPS, expectations were $-0.51. Operator: Good afternoon, ladies and ...

Recently we announced partnerships with SpectronRX, IsoTherapeutics, RadioMedix, and ABX, the details of which ... investments on our Q4 2024 balance sheet. The first source is the cash from ...

This capital, in combination with further anticipated grant funds, strengthens our balance sheet and provides funding ... RadioMedix, and ABx, the details of which can be found in previous press ...

B2B revenue generation, today announced the launch of 6sense® Intelligent Workflows, a new product encompassing Audience and Data workflows that centralizes omnichannel engagement and data management ...

They take a long-term view, looking at average earnings and profit margins over a business cycle, earnings stability, and balance-sheet health ... NEM and Barrick Gold ABX, but it pared most ...

Gold’s surge to record highs is beginning to reinvigorate investor confidence in companies focused on the yellow metal, ...

“Our 2025 EPS growth estimate of up 16 per cent (from up 17 per cent; consensus up 15 per cent) aligns with guidance for EPS ...